What a year 2020 has been! We have been through a lot together, and we at the OBI are celebrating the holiday season and the end of a most unusual year. Look for a 2020 OBI recap in next month’s newsletter. Happy Holidays to you and yours!
2021 is almost here. Stay healthy and safe and we hope to see you in person in the new year!
SUTUREGARD Medical has some great recent wins:
Veana Therapeutics, Inc. Founder and CEO, Emmanuel Akporiaye, Ph.D won the Judges’ Award at the Oregon Bio Digital 2020 Conference held from November 17 -19.
Caregiven is on a roll! Their wins include:
Inherent Targeting won the Judges’ and People’s Choice awards at the early-stage startup pitch contest at Oregon Bio Digital Conference. Additionally, Inherent Targeting has been invited to present at the McKinsey & Co. Early Stage Investor Conference taking place Monday, December 7th.
Aronora announces clinical data to be presented at the 62nd American Society of Hematology Annual Meeting. For more information, see the December 2, 2020 Newswire press release.
Promedix has had 3 large wins that have accelerated clinical adoption and validation:
Keep the wins coming. We love to celebrate your successes!
Great news! You now have the ability to view all of our Lunch and Learns from October, 2019 to the most recent program. These closed caption-enabled videos are available on our website and on our YouTube channel. Subscribe to the Oregon Bioscience Incubator YouTube channel to be notified when new videos are posted, approximately once per month.
Izon Science is the world leading manufacturer of nano-biological separation and characterization tools. Its TRPS measurement system is the most accurate, standardizable and practical method of measuring complex nano-bio particles, while its qEV platform has rapidly become the gold standard in extracellular vesicle separation.
Izon Science joined the OBI on December 1. Welcome, Izon!
Michael McGarry is one of our helpful and engaging mentors in our current Mentoring Program cohort. He is the Founder and President of Forvida, a customer-focused consulting firm passionate about developing health solutions that engage individuals and make health and every day event. Before founding Forvida, Michael had more than 20 years experience in the health care industry, developing innovative programs and medical devices from prototype through FDA approval within small start-up organizations as well as Fortune 500 medical companies.
Michael has been very supportive of the OBI and the larger health sciences ecosystem through his mentoring with OBI, assistance with last spring’s MIT COVID-19 Challenge, the OHSU Invent-a-Thon, and more recently as the presenter for an OBI Virtual Lunch and Learn.
Thank you, Michael, for all you to do to support the community!
Two of OBI’s client companies were winners in the Oregon Bioscience Association’s Digital Conference 2020 pitch event:
Ken Bates, PhD from Bates Medical Systems and Jeff King, PhD from Virogenomics Bio Development also pitched in this fantastic event.
Congratulations to all – you did a great job!
Virtual Lunch & Learn: The 7 Habits of Highly Effective People in R&D
December 9, 2020
Register Now – It’s Almost Full!
COMMUNITY & PARTNER EVENTS
University Lab Partners Presents:
Getting Your Tech Out of the Lab and Onto the Market
December 10, 2020
PDXWIT Event: From Vision to Game Plan
December 10, 2020
TAO CEO Leadership Exchange:
Strengthening Oregon’s Innovation Economy
December 15, 2020
PDXWIT: Annual Celebration + Awards Ceremony
December 15, 2020
Oregon Bio’s Holly Jolly Finale
December 17, 2020
Happy Hour Registration Page